1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes
2024) In Diabetes Care(
- Contribution to journal › Article
-
Mark
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes
(
- Contribution to journal › Article
- 2022
-
Mark
The emotional well-being of parents with children at genetic risk for type 1 diabetes before and during participation in the POInT-study
(
- Contribution to journal › Article
- 2019
-
Mark
Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk : The GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
(
- Contribution to journal › Article
-
Mark
Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD-02 study design and first results
(
- Contribution to journal › Article